ABSSSIs
Use of Dalbavancin in Optimizing the Management of ABSSSIs in Patients With Obesity or Diabetes
This Special Report reviews data on the use of dalbavancin for the treatment of ABSSSIs to support safety and ...
JULY 9, 2024
Reducing the Economic Burden of Hospital Admissions in Treating Patients With ABSSSIs
This Special Report reviews the clinical and economic challenges of acute bacterial skin and skin structure ...
FEBRUARY 1, 2024
FDA Committee Recommends Approval of Omadacycline
The FDA Antimicrobial Drugs Advisory Committee voted in favor of the approval of IV and oral omadacycline (Paratek ...
AUGUST 10, 2018
Load more